查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363298

子宫颈癌诊断市场规模、份额、趋势分析报告：按测试类型、年龄组、最终用途、地区和细分市场预测，2023-2030 年

Cervical Cancer Diagnostic Market Size, Share & Trends Analysis Report By Test Type (Pap Testing Or Cytology Testing, HPV Testing, Colposcopy, Cervical Biopsies), By Age Group, By End Use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

子宫颈癌诊断市场的成长与趋势：

Grand View Research, Inc.最新研究显示，预计2023年至2030年全球子宫颈癌诊断市场规模将以5.7%的年复合成长率成长，2030年将达到70亿美元。

主要促进因素包括子宫颈癌患病上升、筛检技术的进步以及促进常规检查和筛检的各种计划。根据世界卫生组织公布的资料，2012年有超过27万名女性死于子宫颈癌，其中大多数发生在开发中国家。子宫颈癌是女性最常被诊断的癌症之一。子宫颈癌是女性最常见的癌症之一，其原因包括生活方式的改变，例如多个性伴侣、饮酒和吸烟以及压力增加。

此外，越来越多的积极主动的政府配合措施和意识计划预计将在未来年度推动市场成长。美国国家子宫颈癌联盟、世界卫生组织、疾病预防控制中心和美国预防服务工作小组正在努力促进中年女性进行早期子宫颈癌筛检的必要性。

对技术先进的诊断程序的需求不断增加，以促进疾病的早期疗育。产业公司致力于开发创新技术解决方案，以实现准确、高效的结果。筛选技术的进步，例如生物标记的使用，变得越来越重要。技术发展的激增预计将进一步推动行业成长。

由于巴氏试验的日益普及，近年来子宫颈癌的死亡人数显着下降。子宫颈抹片检查有助于及早发现癌前病变，减少子宫颈癌病例的数量。美国癌症协会称，过去40年度来，美国子宫颈癌病例数减少了50%以上。最初，每年进行巴氏试验筛检，导致不必要的程序。然而，美国癌症协会现在建议 21 至 29 岁之间的女性每三年进行一次巴氏检查。

子宫颈癌诊断市场报告亮点：

  • 2022年，巴氏检查部门占了大部分市场占有率，占33.06%。该细分市场的大部分份额归因于早期诊断测试的高效率。人们对早期诊断影响的认识不断提高也促进了该领域的发展。
  • 2022年，北美以45.74%的收益占有率引领区域市场。美国是北美的主要市场。子宫颈癌罹患率的增加以及政府机构以与早期筛检相关的意识提升计划的形式采取的配合措施是该国巨大市场占有率背后的主要要素。
  • 预计亚太地区将呈现良好的成长势头，预测期内年复合成长率为 8.6%。印度、中国和菲律宾等开发中国家政府正在采取各种措施改善卫生基础设施，增加获得卫生设施的机会，这是该地区经济快速成长的一个主要要素。开发中国家癌症的高患病和意识层级的提高也推动了成长。
  • 该市场目前由 Becton、Dickinson and Company、F. Hoffmann-La Roche Ltd、Abbott Laboratories、OncoHealth Corp、Hologic, Inc.、QIAGEN、Quest Diagnostics, Inc. 和 Guided Therapeutics, Inc. 等主要参与企业主导。一​​直由。领先的公司特别专注于开发创新的诊断解决方案。例如，2014年，F. Hoffmann-La Roche Ltd.推出了自动化CINtec PLUS细胞学检测，可有效检测癌前细胞的存在。

目录

第1章调查方法与范围

第2章执行摘要

第3章子宫颈癌诊断市场变数、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 产业价值链分析
    • 赎回框架
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 子宫颈癌诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略联盟分析
    • 打入市场策略

第4章子宫颈癌诊断市场：按测试类型的估计和趋势分析

  • 子宫颈癌诊断市场，按测试类型分類的要点
  • 子宫颈癌诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 巴氏抹片检查
  • HPV检测
  • 阴道镜检查
  • 子宫颈切片检查
  • 膀胱镜检查

第5章子宫颈癌诊断市场：依年龄组别估算及趋势分析

  • 子宫颈癌诊断市场，依年龄组别分類的要点
  • 子宫颈癌诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 20-40岁
  • 40岁以上

第6章子宫颈癌诊断市场：最终用途的估计和趋势分析

  • 子宫颈癌诊断市场，依最终用途分類的要点
  • 子宫颈癌诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院
  • 实验室
  • 诊断中心

第7章子宫颈癌诊断市场：区域估计及趋势分析

  • 区域展望
  • 按地区分類的子宫颈癌诊断市场：市场要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • Abbott Laboratories
    • Ouigan NV
    • Thermo Fisher Scientific Inc
    • Dickinson and Company
    • Hologic Inc
    • CooperSurgical Inc
    • Siemens Healthineers
Product Code: GVR-1-68038-127-6

Cervical Cancer Diagnostic Market Growth & Trends:

The global cervical cancer diagnostic market size is expected to reach USD 7.0 billion by 2030, growing at a CAGR of 5.7% from 2023 to 2030, according to a new study conducted by Grand View Research, Inc.. The key driving factors include the rising prevalence of cervical cancer, evolving screening technology, and various programs that promote routine check up and screening. According to the data published by the WHO, in 2012, over 270,000 women died due to cervical cancer, majority of which were from the developing countries. It is one of the most common cancer type diagnosed in women. Some of the etiological factors are multiple sex partners, and changing lifestyle, such as drinking & smoking and increased stress levels.

Furthermore, favorable government initiatives and increasing number of awareness programs are further expected to promote the market growth in coming few years. The National Cervical Cancer Coalition, WHO, CDC, the U.S. Preventive Services Task Force, are working towards promoting the necessity for early screening of cervical cancer amongst mid aged women.

There is an increasing demand for technologically advanced diagnostic procedures that facilitate the early intervention of the disease. The industry players are focused on developing innovative technological solutions for accurate and efficient results. Advancement in screening techniques, such as use of biomarkers, is gaining importance. The upsurge in technological developments is anticipated to further drive industry growth.

On account of increasing adoption of Pap test, the number of deaths due to cervical cancer has declined significantly in past few years. It helps detect precancerous lesions at an early state and, thus, reduces the number of cervical cancer cases. The American Cancer Society stated that the cervical cancer cases in last 40 years in the U.S. have declined by more than 50%. Initially, the Pap test screening was carried out every year which lead to further unnecessary procedures. However, the American Cancer Society now recommends that women in the age group of 21 to 29 should undergo Pap test every 3 years.

Cervical Cancer Diagnostic Market Report Highlights:

  • In 2022, the Pap testing segment held majority of the market share of 33.06%. The segment's large share can be attributed to the high efficiency of the tests in early diagnosis. Also, the increasing awareness about the impact of early diagnosis contributed to its growth.
  • In 2022, North America was the leading regional market with a revenue share of 45.74%. The U.S. is a key market in North America. Growing incidence of cervical cancer coupled with initiatives undertaken by government agencies in the form of awareness programs pertaining to the early screening of the disease are key factors for the country's large market share.
  • Asia Pacific is expected to witness lucrative growth over the forecast period growing at a CAGR of 8.6%. The various steps undertaken by governments of developing countries such as India, China, Philippines, and other in order to improve healthcare infrastructure and to improve access to healthcare facilities are amongst key factors attributing to region's high growth. Also, high prevalence of cancer in developing nations and increasing consumer awareness levels drive the growth
  • This market is presently dominated by a few key participants such as Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Abbott Laboratories, OncoHealth Corp, Hologic, Inc., QIAGEN, Quest Diagnostics, Inc and Guided Therapeutics, Inc. The key players focus specially on developing innovative solutions for diagnosis. For instance, F. Hoffmann-La Roche Ltd., in 2014, launched automated CINtec PLUS cytology test that efficiently detects the presence of precancerous cells.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. Age group
    • 1.1.3. End use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Age group outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cervical Cancer Diagnostic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. The increasing demand for cervical cancer screening tools
      • 3.4.1.2. Increase in cervical cancer cases across the globe
      • 3.4.1.3. Technological advancements
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Limited number of approved products
      • 3.4.2.2. Complications/risks associated with microneedles
  • 3.5. Cervical Cancer Diagnostic Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Cervical Cancer Diagnostic Market: Test Type Estimates & Trend Analysis

  • 4.1. Cervical Cancer Diagnostic Market, By Test Type Key Takeaways
  • 4.2. Cervical Cancer Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Pap Testing
    • 4.3.1. Pap testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. HPV Testing
    • 4.4.1. HPV testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Colposcopy
    • 4.5.1. Colposcopy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Cervical Biopsies
    • 4.6.1. Cervical biopsies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Cystoscopy
    • 4.7.1. Cystoscopy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cervical Cancer Diagnostic market: Age group Estimates & Trend Analysis

  • 5.1. Cervical Cancer Diagnostic Market, By Age group Key Takeaways
  • 5.2. Cervical Cancer Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. 20-40 years
    • 5.3.1. 20-40 years market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Above 40 years
    • 5.4.1. Above 40 years market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cervical Cancer Diagnostic market: End Use Estimates & Trend Analysis

  • 6.1. Cervical Cancer Diagnostic Market, By End Use Key Takeaways
  • 6.2. Cervical Cancer Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Laboratories
    • 6.4.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Diagnostic centers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cervical Cancer Diagnostic Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Cervical Cancer Diagnostic Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Abbott Laboratories
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Ouigan NV
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Thermo Fisher Scientific Inc
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Dickinson and Company
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Hologic Inc
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. CooperSurgical Inc
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Siemens Healthineers
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 4 North America cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 7 U.S. cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 8 U.S. cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 10 Canada cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 11 Canada cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Europe cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 14 Europe cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Germany cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 18 Germany cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 20 UK cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 21 UK cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 23 France cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 24 France cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 26 Italy cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 27 Italy cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Spain cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 30 Spain cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Sweden cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Sweden cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 33 Sweden cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Norway cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 35 Norway cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 36 Norway cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Denmark cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Denmark cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 39 Denmark cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 44 China cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 45 China cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 46 China cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 48 Japan cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 49 Japan cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 51 India cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 52 India cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Thailand cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 54 Thailand cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 55 Thailand cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 57 South Korea cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 58 South Korea cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Latin America cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 60 Latin America cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 61 Latin America cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 63 Brazil cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 64 Brazil cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 65 Brazil cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Mexico cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 67 Mexico cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 68 Mexico cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Argentina cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 70 Argentina cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 71 Argentina cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Middle East and Africa cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 76 South Africa cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 77 South Africa cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 78 South Africa cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 82 UAE cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 83 UAE cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 84 UAE cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Kuwait cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 86 Kuwait cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 87 Kuwait cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cervical cancer diagnostic: Market outlook
  • Fig. 9 Cervical cancer diagnostic: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cervical cancer diagnostic market driver impact
  • Fig. 15 Cervical cancer diagnostic market restraint impact
  • Fig. 16 Cervical cancer diagnostic market strategic initiatives analysis
  • Fig. 17 Cervical cancer diagnostic market: Test Type movement analysis
  • Fig. 18 Cervical cancer diagnostic market: type outlook and key takeaways
  • Fig. 19 Pap testing market estimates and forecasts, 2018 - 2030
  • Fig. 20 HPV testing market estimates and forecasts, 2018 - 2030
  • Fig. 21 Colposcopy market estimates and forecasts, 2018 - 2030
  • Fig. 22 Cervical biopsies market estimates and forecasts, 2018 - 2030
  • Fig. 23 Cytoscopy market estimates and forecasts, 2018 - 2030
  • Fig. 24 Cervical cancer diagnostic market: Age-group movement analysis
  • Fig. 25 Cervical cancer diagnostic market: age-group outlook and key takeaways
  • Fig. 26 20-40 years market estimates and forecasts, 2018 - 2030
  • Fig. 27 Above 40 years market estimates and forecasts, 2018 - 2030
  • Fig. 28 Cervical cancer diagnostic market: End use movement analysis
  • Fig. 29 Cervical cancer diagnostic market: end use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 31 Laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 32 Diagnostic centers management market estimates and forecasts, 2018 - 2030
  • Fig. 33 Global Cervical cancer diagnostic market: Regional movement analysis
  • Fig. 34 Global Cervical cancer diagnostic market: regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 41 France market estimates and forecasts, 2018 - 2030
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 48 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 49 China market estimates and forecasts, 2018 - 2030
  • Fig. 50 India market estimates and forecasts, 2018 - 2030
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 58 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 59 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 60 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 61 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030